Dextromethorphan Hydrobromide Tablets

This product is a central antitussive drug that can inhibit the cough center in the medulla oblongata to produce an antitussive effect. Its antitussive effect is equal to or slightly stronger than that of codeine. The general therapeutic dose does not inhibit breathing, and long-term use is non-addictive and non-tolerant. This product is well absorbed orally and takes effect within 10-30 minutes after taking the drug.

Dextromethorphan hydrobromide.

This product is white tablets.

This product is suitable for dry cough without sputum, including frequent and severe cough.

Oral administration. Adults: 1-2 tablets at a time, 3-4 times a day.

Symptoms include dizziness, headache, drowsiness, irritability, belching, lack of appetite, constipation, nausea, skin allergies, etc., but they do not affect the efficacy. The above reactions will disappear on their own after stopping the drug. Overdose can cause unconsciousness, bronchospasm, and respiratory depression.

It is contraindicated for women who are within 3 months of pregnancy, those with a history of mental illness, and breastfeeding women. It is contraindicated for patients who have stopped taking monoamine oxidase inhibitors for less than two weeks.

Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Pregnant women within three months of pregnancy and lactating women are prohibited. Precautions for the elderly: Not yet clear.

1. This product should not be used with antipsychotics. 2. This product should not be used with ethanol and other central nervous system depressants. 3. If you are taking other medicines, please consult a doctor or pharmacist before using this product.

Keep away from light, tightly closed, in a cool place.

15 mg

24 months.

Yiling Pharmaceutical Ltd.

• Founded in:

  2014-07-28

• Address:

  No. 36, Zhujiang Avenue, Shijiazhuang High-tech Zone

• Tax NO.:

  911301013989550179

• Registered Funds:

  675 million yuan

• Website:

  Log in to view

• Email:

  Log in to view